• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Lacosamide may be safe and effective supplemental anti-epileptic drug

bys25qthea
March 7, 2013
in Chronic Disease, Neurology
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

[tabs tab1=”2MM Rundown” tab2= “2MM Full Report”]

[tab]

Image: PD

1. Lacosamide functions well as an add-on anti-epileptic drug (AED), decreasing frequency of seizures in 66% of patients with brain tumors.

2. Lacosamide is well tolerated with the majority (77%) of patient experiencing no side effects.

This retrospective study demonstrates the potential for lacosamide to be effective and safe as an add-on therapy for recurrent seizures in patients with brain tumors. The drug has many strengths as an AED for use specifically with brain tumor patients. Key attributes include lack of interactions with hepatic enzymes and low potential for drug interactions, useful for patients on extensive chemotherapy regimens. Given that this was a retrospective medical record review, it is subject to the typical limitations of a retrospective studies. However, the data presented does favor use of lacosamide as an AED in brain tumor patients, and a prospective study to clearly delineate the safety and efficacy of the drug is justified and warranted.

Click to read the study in JNS

RELATED REPORTS

New prognostication tool predicts neurological deficits and long-term survival in patients with status epilepticus

Treatment of rhythmic and periodic EEG patterns in comatose survivors of cardiac arrest

Pregnant patients with epilepsy may benefit from increased doses of anticonvulsant medications

Click to read an accompanying editorial in JNS

[/tab]

[tab]

Image: PD

1. Lacosamide functions well as an add-on anti-epileptic drug (AED), decreasing frequency of seizures in 66% of patients with brain tumors.

2. Lacosamide is well tolerated with the majority (77%) of patient experiencing no side effects.

This [retrospective, multicenter] study reviewed medical records from 5 US academic institutions, identifying over 70 patients with primary brain tumors who were taking lacosamide. A majority of these patients (74%) were taking lacosamide for recurrent seizures. 66% of patients reported decreased seizure frequency and 30% report stable seizures. 23% of patients required an additional AED to control their seizures. Of note, lacosamide was most effective in combination with levetiracetam compared to monotherapy (71% vs 33% decreased seizure frequency). The drug was well tolerated with 77% of patients reporting no toxicity. The most common side effect encountered was fatigue (6%), followed by dizziness, nausea, confusion, and weakness (2% each).  

In sum: This retrospective study demonstrates the potential for lacosamide to be effective and safe as an add-on therapy for recurrent seizures in patients with brain tumors. The drug has many strengths as an AED for use specifically with brain tumor patients. Key attributes include lack of interactions with hepatic enzymes and low potential for drug interactions, useful for patients on extensive chemotherapy regimens. Given that this was a retrospective medical record review, it is subject to the typical limitations of a retrospective studies. However, the data presented does favor use of lacosamide as an AED in brain tumor patients, and a prospective study to clearly delineate the safety and efficacy of the drug is justified and warranted.

Click to read the study in JNS

Click to read an accompanying editorial in JNS 

By Allen Ho and Marc Succi

© 2013 2minutemedicine.com. All rights reserved. No works may be reproduced without written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT. Content is produced in accordance with fair use copyrights solely and strictly for the purpose of teaching, news and criticism. No benefit, monetary or otherwise, is realized by any participants or the owner of this domain.

[/tab]

[/tabs]

Tags: epilepsylacosamideseizures
Previous Post

Childhood ADHD associated with increased risk of suicide [Physician Comment]

Next Post

Low infection risk with neurologic endovascular procedures

RelatedReports

Neurology

New prognostication tool predicts neurological deficits and long-term survival in patients with status epilepticus

April 15, 2022
Patient Basics: Electroencephalogram (EEG)
Cardiology

Treatment of rhythmic and periodic EEG patterns in comatose survivors of cardiac arrest

March 2, 2022
USPSTF finds insufficient evidence for screening for iron deficiency anemia during pregnancy
Neurology

Pregnant patients with epilepsy may benefit from increased doses of anticonvulsant medications

February 16, 2022
Quick Take: Functional Outcome of Intravenous Thrombolysis in Patients With Lacunar Infarcts in the WAKE-UP Trial
Emergency

Cardiovascular and all-cause mortality in patients with poststroke epilepsy associated with choice of antiseizure medication

December 18, 2021
Next Post
Low infection risk with neurologic endovascular procedures

Low infection risk with neurologic endovascular procedures

Maternal factors increase odds of congenital vertebral malformations by 6x

Maternal factors increase odds of congenital vertebral malformations by 6x

Salt intake linked with autoimmune disease

Salt intake linked with autoimmune disease

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

Get 2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • 2 Minute Medicine Rewind May 22nd, 2022
  • #VisualAbstract: Severe actinic keratosis and need for additional treatment are markers for an increased risk of cutaneous squamous cell carcinoma
  • Virtual yoga and meditation intervention may be associated with increased health-related quality of life
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.